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PART I. CLINICAL, BIOCHEMICAL AND IMMUNOCHEMICAL ASPECTS
G. SHULMAN, K. STEVENS, D. B. BERNARD, T. H. BOTHWELL,
W.R. BEZWODA, S.R.LYNCH
SUMMARY
The clinical, biochemical and immunochemical features of
52 patients suffering from multiple myelomatosis are re-
ported. Three major criteria were used to establish the
diagnosis: serum and urine protein chemistry, bone
marrow morphology and the radiological appearances of
bone. The fact that abnormalities of gamma globulin
synthesis were present in 49 of the 52 patients indicates
the importance of adequate examination of urine by
electrophores's and immunochemical techniques in the
early diagnosis of multiple myeloma. Bradshaw's test,
which is a simple screening test for fence-Jones pro-
teinuria, was positive in 63% of patients.
S. Afr. Med. J., 48, 1023 (1974).
The demonstration of disordered gamma globulin synthesis
is an important criterion in the diagnosis of multiple
myelomatosis: Presently available methods permit the
identification of different immunochemical classes of gam-
ma globulins. The immunochemical class of a paraprotein
('M'-component) may have an important bearing on the
prognosis and management of patients \',ith multiple
myelomatosis.' Moreover, accurate quantitation of para-
proteinaemia and Bence-Jones proteinuria is ex~:emely
helpful in assessing a patient's response to therapy."-·
In this report the clinical, biochemical and immuno-
chemical features of 52 patients suffering from multiple
myebmatosis are reviewed. Special reference is made to
the use of currently available techniques for identifying
and quantitating abnormal protein synthesis, and to the
interpretation of screening tests which can be used at the
bedside to detect Bence-Jones proteinuria.
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The diagnosis of multiple myelomatosis was based upon
the finding of radiological abnormalities of bone, on the
morphological features of a bone marrow aspirate, and
on the results of serum and urine protein studies.
Radiological Criteria
Radiographs of any tender bones were studied. In the
absence ef bony tenderness, a limited radiological skeletal
survey was done.
Bone Marrow Examination
The characteristic bone marrow abnormality in myelo-
matosis is the presence of 'myeloma cells', which are
atypical plasma cells with punched-out nucleoli. The pre-
sence of such cells, which usually accounted for more
than 10°6 of the nucleated cells in the aspirate, was
regarded as diagnostic.
Serum and Urine Protein Studies
Serum and early morning urine samples preserved with
sodium azide (1 mgjml) were examined. Sera were stored
at 4 - 6°C until the investigations were completed, and
then froz,:n in 0,5-ml aliquots at -20°e. Repeat analyses
were performed on a thawed aliquot which was then
discarded.
The salicylsulphonic acid test and Bradshaw's test' were
used as screening tests for proteinuria. The former detects
albumin and globulins, and is performed by a dropwise
addition of 1O~0 salicylsulphonic acid to urine. Bradshaw's
test detects only the presence of globulin and is performed
by layering clear, filtered urine on concentrated hydro-
chloric acid so as to form two unmixed layers. A positive
result for the presence of globulins is the formation of
a precipitate of protein at the urine-acid interface (Fig. 1).
A further aliq uot of urine was then prepared for
electrophoresis by concentrating it, using a Sartorius con-
centration apparatus, until the protein concentration was
approximately 0,5 - I gj lOO m!.
The total protein of both serum and urine was estimated
by a biuret technique.' Serum protein fractions were
quantitatively measured using a standard cellulose acetate
microzone electrophoretic technique (Beckman Microzone
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Fig. I. Screening tests for the presence of globulin.
Extreme lefi: Bradshaw's test is positive in urine
showing a Bence-Jones band on electrophoresis. Urine
total protein was 120 mg/IOO m1. Left: Negative Brad-
shaw's test. Right: Weakly positive Bradshaw's with
urine showing non-selective proteinuria on electro-
phoresis. Extreme right: The same urine as in (right)
tested with 10% salicylsulphonic acid.
Apparatus). Cognisance was taken of the limitations of
the protein binding of the dye, Ponceau S, used as the
protein stain." The linearity of the relationship between
the optical density and the concentration of paraprotein
bands up to 6,0 g/100 ml was verified.
Electrophoresis of serum and concentrated urine was
performed simultaneously on 5-cm cellulose acetate strips
(Beckman) using application points at the same horizontal
origin (Fig. 2). With the aid of a Pasteur micropipette,
5 1-'-1 of each was applied over a width of 1,5 - 2 cm.
twice in 10°0 acetic acid in methanol for 10 minutes. and
finally twice with pure methanol for 10 minutes. The
electrophoretic appearance of the sample of concentrated
urine was used as conclusive proof of the presence of
Bence-Jones protein, and a visual quantitative estimate of
the Bence-Jones fraction was made. Immuno-electrophore-
sis was performed by running the samples in 100 agar gel
in electrophoresis buffer on microscope slides in a Shandon
electrophoresis tank. Appropriate antisera (Hyland, Beh-
ringworke AG) were used and the results of the light
chain typing were read between 2 and 4 hours after the
antiserum had been applied (Fig. 3). The results of heavy
Fig. 3. Two different type kappa immuno-electrophoretic
arcs due to Bence-Jones protein (upper trough) and one
type lambda Bence-Jones protein (lower trough). The
urine samples were applied to the wells.
chain typing were read after approximately 20 hours,
although in many instances the results were positive from
about 4 hours (Fig. 4). It was found that the results of
urine electrophoresis were best read 4 hours after applying
the antiserum, since precipitin arcs occasionally dis-







Fig. 4. Immuno-electrophoretic appearances of two IgG
paraproteins 20 hours after application of antiserum
(upper trough). Marked diminution in serum IgA in
both patients caused failure of development of reaction
to IgA antiserum (lower trough). The serum samples
were applied to the wells. Antisera were applied to the
troughs.
Fig. 2. Electrophoretic preparation of serum and urine
performed coincidentally. Both samples were applied at
the same transverse level.
The strips were run in a barbitone buffer, pH 8,6 for
I hour at 200 V in a Shandon electrophoresis tank.
The strips were stained with 0,25°~ naphthalene black
10 B in absolute methanol containing 3%- trichloracetic
acid. After 10 minutes the strips were destained by washing
In every case serum immunoglobulins other than the
paraprotein were determined by radial immunodiffusion."
R::sults were expressed in international units per ml
(lU/m!) using a pooled serum standard which had been
calibrated against the World Health Organisation Inter-
nationaL Reference Standard 67/97." Paraproteins were
not measured by immunodiffusion, since their idiotypic
behaviour in different patients led to erroneous results
being obtained.
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RESULTS
Clinical Features
Fifty-two patients have been treated at the Haematology
Clinic of the Johannesburg Gene'ral Hospital since 1965.
Of these, 22 were males (mean age 58,7 years, range 38-84
years) and 30 were females (mean age 64,6 years, range
44 - 86 years); and 71 % were over 60 years of age.
The most common presenting symptoms were bone
pain 65% and those associated with anaemia 40%. Others
were pathological fractures 21 o~, recurrent infections 19%,
fever 6%, weight lms 13°0 and miscellaneous 15%.
Symptoms had been present for more than 3 months in
38 % of patients.
Physical examination demonstrated bone tenderness in
16 patients (30%), splenomegaly in 9 and hepatomegaly in
6, while 22 patients were entirely normal.
Thirty-three patients (63'%) were anaemic, with haemo-
globin concentrations less than 11,5 g/l00 ml, and the
erythrocyte sedimentation rate was raised (>20 mm/first
hour Westergren) in 47. Hyperuricaemia (serum uric acid
>6,5 mg/lOO ml) was present in 25 patients, and renal
insufficiency (urea >40 mg/lOO ml, serum creatinine> 1,5
mg/lOO ml, creatinine clearance <80 ml/min) in 18. A
serum calcium greater than 5,5 mEq/litre was present in
6 patients.
Diagnostic Criteria
Eighty-three per cent of the patients showed radiological
evidence of myeloma deposits in bone. The most frequently
involved bones were the skull (40%) and the spine (34%).
Bone marrow examination showed evidence of infiltration
with myeloma cells in 40 of 43 patients in whom it was
done. Abnormal globulins were demonstrated in 49 patients.
At least 2 of these 3 major criteria of multiple myeloma-
tosis were present in all patients.
Twenty-three patients presented with an abnormal
elevation in the serum total protein, due mainly to para-
protein ('M'-component). In 14 patients there was hypo-
albuminaemia (serum albumin <3,0 g/lOO ml), and in
one patient hypoproteinaemia (serum total protein <6,5
g/lOO ml) in association with a daily Bence-Jones protein
excretion of more than 30 g. The 'M'-component was
greater than 1,0 g/lOO ml in 46 patients at the time of
diagnosis, concentrations ranging between 1,0 and 7,4
g/l00 m1 (mean 3,8 g/l00 ml). No serum 'M'-component
was identified in 6 patients, but in 3 of them Bence-Jones
protein was detected in the urine in a concentration
greater than 100 mg/lOO m!.
IgG myelomatosis occurred in 36 patients,. IgA in 9
and Bence-Jones myelomatosis in 3. One. case of IgD
myelomatosis was found_ In _3 patients in whom the
diagnosis was made on marrow morphology and the
radiographic appearances of bone, no serum paraprotein
was detected and urine was not examined. A marked
reduction in the concentration of serum immunoglobulins
was found in 43 patients. This applied particularly to the
group with IgG paraproteins. Patients with IgA or Bence-
Jones myelomatosis showed only slight or moderate
immune paresis.
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Elecn:ophoresis of concentrated urine showed a Bence-
Jones band in 34 patients. Forty-two per cent were type
kappa and 58'10 type lambda. The total protein concen-
tration in the urine was greater than 20 rng/lOO ml in
88~0 of them. Analysis of the protein showed the additional
presence of albumin in 67°'0, transferrin in 50% and the
paraprotein in 25~0. Urine examination for protein in
the remaining patients tested was negative. The salicyl-
sulphonic acid test was positive in all patients with
albuminuria, but in only 75°0 of patients with Bence-Jones
proteinuria. Bradshaw's test, which was used as a screening
test for Bence-Jones protein and does not detect the
presence of albumin, was positive in 63% of the patients
in whom a Bence-Jones protein band was identified on
electrophoresis. Electrophoresis of some patients'- urine
specimens showed a band simulating a Bence-Jones protein
band' in the late beta region of the electrophoretic strip,
which failed to react with light chain or Hence-Jones
protein antisera. These cases gave a p03itive reaction with
antiserum to transferrin.
DISCUSSION
Multiple myeloma has in the past usually been reported
to occur more commonly in men. In the present series
58°{, of patients were women, the female predominance
being particularly striking in the older patients. This finding
supports the suggestion that a change in the sex distri-
bution has occurred recently." The explanation for the
apparent change is unknown. Our clinical findings were
similar to those reported from other centres." It is
important to note the absence of any physical abnormality
in 42% of patients despite the frequent presence of
advanced disease.
The early diagnosis of multiple myeloma usually depends
upon the detection of abnormalities of globulin synthesis.
In a mouse plasmacytoma model it was shown that the
level of serum paraprotein reflects the size of the
tumour;H,15 the number of tumour cells and the amount
of paraprotein increase exponentially and are correlated
with each other. Similar conclusions were reached in
patients in whom the diagnosis was subsequently esta-
blished." It has been estimated on the basis of median
tumour cell doubling times that a serum IgG paraprotein
may first be detected when the immunocytoma has a
mass as small as 20 g.l8 Bence-Jones protein can be detected
with certainty at a level as low as 15 mg/24 hours if the
urine is concentrated 300 times.H This quantity of Bence-
Jones protein could be produced by as little as 3 g of
immunocytoma.lS Since the tumour mass at the time of
clinical presentation is probably about I kg it is estimated
that detectable biochemical abnormalities may precede
symptoms by as long as 5 years.lS The need for careful
immunochemical examination of serum and concentrated
urine specimens is therefore readily apparent. Abnorma-l
globulin synthesis was present in 49 of the 52 patients
in this investigation.
Screening tests for Bence-Jones protein may be mis-
leading. Bradshaw's test has been found to be unsurpassed
as a screening test,l9 being positive in 95% of urine
specimens containing Bence-Jones protein in concentrations
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greater than 5 mg/IOO ml. A posItive result was obtained
in only 63% of patients with Bence-Jones proteinuria in
the present investigation. Morwver, other globulins which
were character;sed by means of electrophore,is ,and
immuno-elect~ophoresis, also sometimes led to a positive
screening result in the urine. Albustix (Ames Co., Miles
Laborat::Jries Inc., USA) cannot be used to detect Berice-
Jones protein, and salicylsulphonic acid, although sensi-
t'ive, lacks ~pecificity and give's a positive result for most
proteins in the urine.
It is noteworthy that in the present investigation one
quarter of patients with Eence-Jones proteinuria would
have been missed if adequately concentrated urine had
not been subjected to electrophoresis. The urine of any
person suspected of having multiple myelomatosis should
therefore be concentrated and submitted to electrophoresis.
If a band is found on electrophoresis, immuno-electro-
phoresis must then be done in order to characterise the
immunochemical specificity of the Bence-Jones band.
Professor Bothwell was in receipt of grants from the South
African Medical Research Council and the Atomic Energy
Board.
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The results of the use of melphalan in 52 patients with
multiple myeloma have been analysed. The median survival
of the whole group of patients was 30 months, and of those
w:th renal insufficiency only 12,5 months. Bence-lones
proteinuria was also a poor prognostic finding,. but only
because of its association with renal failure. Patients with
Bence-Jones protcinur;a and normal renal function had a
median survival of 41 months. Responsiveness to therapy
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by criteria based on those of the Chronic Leukemial
Multip!e Myeloma Task Force could be assessed in 25
patients. Dramatic symptomatic relief occurred in all but
one of the responsive patients, but in only one-fifth of those
who did not respond to therapy.
S. Afr. Med. J., 48, 1026 (1974).
The value of melphalan in the treatment of multiple
myeloma has been demonstrated in a number of investi-
gations.'" Symptoms are usually ameliorated, and the
median survival, calculated from the time of diagnosis, is
24 months or more in patients treated with melphalan, and
less than a year when the patients are untreated.',3 This
article analyses the experience of the Haematology Clinic
of Johannesburg General Hospital in using melphalan
in the treatment of patients with multiple myeloma.
METHODS
The patient-population, the clinical, radiological, haema-
tological and biochemical abnormalities recorded at the
time of presentation, and the criteria used for establishing
the diagnosis of multiple myeloma have been described
in detail.'
